Dietary lipids and functional gastrointestinal disorders

American Journal of Gastroenterology

Volumn 108, Issue 5, 2013, Pages 737-747

  Feinle Bisset, Christine ^a   Azpiroz, Fernando ^b,c,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GLUCAGON LIKE PEPTIDE 1; LIPID; PEPTIDE YY; TRIACYLGLYCEROL;

ARTICLE; BLOATING; BODY WEIGHT; CALORIC INTAKE; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; FAT INTAKE; FOOD COMPOSITION; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LIPOLYSIS; PRIORITY JOURNAL; PROVOCATION TEST; STOMACH PARESIS; SYSTEMATIC REVIEW;

DIARRHEA; DIETARY FATS; DIGESTION; DYSPEPSIA; EATING; EVIDENCE-BASED MEDICINE; FOOD HABITS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; INTESTINAL ABSORPTION; IRRITABLE BOWEL SYNDROME;

EID: 84877579879     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.76     Document Type: Article

References (136)

1. Halpert A, Dalton CB, Palsson O et al. Patient educational media preferences for information about irritable bowel syndrome (IBS) . Dig Dis Sci 2008; 53: 3184-90.
2. Marciani L, Faulks R, Wickham MS et al. Effect of intragastric acid stability of fat emulsions on gastric emptying, plasma lipid profi le and postprandial satiety . Br J Nutr 2009; 101: 919-28.
3. Marciani L, Wickham M, Singh G et al. Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction . Am J Physiol Gastrointest Liver Physiol 2007; 292: G1607-13.
4. Meyer JH, Elashoff JD, Lake R . Gastric emptying of indigestible versus digestible oils and solid fats in normal humans . Dig Dis Sci 1999; 44 : 1076-82.
5. Meyer JH, Hlinka M, Kao D et al. Gastric emptying of oil from solid and liquid meals. Effect of human pancreatic insuffi ciency . Dig Dis Sci 1996; 41: 1691-9.
6. Seimon RV, Wooster T, Otto B et al. The droplet size of intraduodenal fat emulsions infl uences antropyloroduodenal motility, hormone release, and appetite in healthy males . Am J Clin Nutr 2009; 89: 1729-36.
7. Hamer HM, Jonkers D, Venema K et al. Review article: the role of butyrate on colonic function . Aliment Pharmacol Ther 2008; 27: 104-19.
8. Borovicka J, Schwizer W, Guttmann G et al. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specifi c lipase inhibitor . Gut 2000; 46: 774-81.
9. Degen L, Drewe J, Piccoli F et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men . Am J Physiol Regul Integr Comp Physiol 2007; 292: R1391-9.
10. Degen L, Matzinger D, Drewe J et al. Role of free fatty acids in regulating gastric emptying and gallbladder contraction . Digestion 2006; 74: 131-9.
11. Feinle C, O ' Donovan D, Doran S et al. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans . Am J Physiol Gastrointest Liver Physiol 2003; 284: G798-807.
12. Feinle C, Rades T, Otto B et al. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001; 120: 1100-7.
13. Feinle-Bisset C, Patterson M, Ghatei MA et al. Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid . Am J Physiol Endocrinol Metab 2005; 289: E948-53.
14. Matzinger D, Degen L, Drewe J et al. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans . Gut 2000; 46: 688-93.
15. O ' Donovan D, Feinle-Bisset C, Wishart J et al. Lipase inhibition attenuates the acute inhibitory Effects of oral fat on food intake in healthy subjects. Br J Nutr 2003; 90: 849-52.
16. Pilichiewicz A, O ' Donovan D, Feinle C et al. Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus . J Clin Endocrinol Metab 2003; 88: 3829-34.
17. Schwizer W, Asal K, Kreiss C et al. Role of lipase in the regulation of upper gastrointestinal function in humans . Am J Physiol 1997; 273 : G612-20.
18. Meyer JH, Hlinka M, Tabrizi Y et al. Chemical specifi cities and intestinal distributions of nutrient-driven satiety . Am J Physiol 1998; 275: R1293-307.
19. Pilichiewicz AN, Papadopoulos P, Brennan IM et al. Load-dependent Effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men . Am J Physiol Regul Integr Comp Physiol 2007; 293: R2170-8.
20. Deiteren A, Camilleri M, Burton D et al. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci 2010; 55: 384-91.
21. Hunt JN, Knox MT . A relation between the chain length of fatty acids and the slowing of gastric emptying . J Physiol 1968; 194: 327-36.
22. Feltrin KL, Little TJ, Meyer JH et al. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length . Am J Physiol Regul Integr Comp Physiol 2004; 287: R524-33.
23. Feltrin KL, Patterson M, Ghatei MA et al. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men . Peptides 2006; 27: 1638-43.
24. McLaughlin J, Grazia Luca M, Jones MN et al. Fatty acid chain length determines cholecystokinin secretion and Effect on human gastric motility. Gastroenterology 1999; 116: 46-53.
25. Accarino AM, Azpiroz F, Malagelada JR . Modifi cation of small bowel mechanosensitivity by intestinal fat . Gut 2001; 48: 690-5.
26. Caldarella MP, Azpiroz F, Malagelada JR . Selective Effects of nutrients on gut sensitivity and refl exes . Gut 2007; 56: 37-42.
27. Feinle C, Grundy D, Read NW . Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension . Am J Physiol 1997; 273: G721-6.
28. Feinle C, Meier O, Otto B et al. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia . Gut 2001 ; 48: 347-55.
29. Feinle C, Grundy D, Fried M . Modulation of gastric distension-induced sensations by small intestinal receptors . Am J Physiol Gastrointest Liver Physiol 2001; 280: G51-7.
30. Feinle C, Grundy D, Otto B et al. Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1217-23.
31. Boyd KA, O ' Donovan DG, Doran S et al. High-fat diet Effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men. Am J Physiol Gastrointest Liver Physiol 2003; 284: G188-96.
32. Cunningham KM, Daly J, Horowitz M et al. Gastrointestinal adaptation to diets of diff ering fat composition in human volunteers . Gut 1991; 32: 483-6.
33. French SJ, Murray B, Rumsey RD et al. Adaptation to high-fat diets: Effects on eating behaviour and plasma cholecystokinin . Br J Nutr 1995; 73: 179-89.
34. Little TJ, Feltrin KL, Horowitz M et al. A high-fat diet raises fasting plasma CCK but does not aff ect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men . Am J Physiol Regul Integr Comp Physiol 2008; 294: R45-51.
35. Brennan IM, Seimon RV, Luscombe-Marsh ND et al. Effects of acute dietary restriction on gut motor, hormone and energy intake responses to duodenal fat in obese men . Int J Obes (Lond) 2011; 35: 448-56.
36. Azpiroz F, Bouin M, Camilleri M et al. Mechanisms of hypersensitivity in IBS and functional disorders . Neurogastroenterol Motil 2007; 19: 62-88.
37. Kellow JE, Azpiroz F, Delvaux M et al. Applied principles of neurogastroenterology: physiology/motility sensation . Gastroenterology 2006; 130 : 1412-20.
38. Caldarella MP, Milano A, Laterza F et al. Visceral sensitivity and symptoms in patients with constipation-or diarrhea-predominant irritable bowel syndrome (IBS): Effect of a low-fat intraduodenal infusion . Am J Gastroenterol 2005; 100: 383-9.
39. Simren M, Abrahamsson H, Bjornsson ES . Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors . Clin Gastroenterol Hepatol 2007; 5: 201-8.
40. van Boxel OS, ter Linde JJ, Oors J et al. Duodenal lipid-induced symptom generation in gastroesophageal refl ux disease: role of apolipoprotein A-IV and cholecystokinin . Neurogastroenterol Motil 2012; 24: 350-e168.
41. Barbera R, Feinle C, Read NW . Nutrient-specifi c modulation of gastric mechanosensitivity in patients with functional dyspepsia . Dig Dis Sci 1995; 40: 1636-41.
42. Barbera R, Feinle C, Read NW . Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia . Eur J Gastroenterol Hepatol 1995; 7: 1051-7.
43. Serra J, Salvioli B, Azpiroz F et al. Lipid-induced intestinal gas retention in irritable bowel syndrome . Gastroenterology 2002; 123: 700-6.
44. Lacy BE, Carter J, Weiss JE et al. The Effects of intraduodenal nutrient infusion on serum CCK, LES pressure, and gastroesophageal refl ux. Neurogastroenterol Motil 2011; 23: 631-e256.
45. Simren M, Agerforz P, Bjornsson ES et al. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol Motil 2007; 19: 20-9.
46. El-Serag H . Role of obesity in GORD-related disorders . Gut 2008; 57 : 281-4.
47. Clave P, Gonzalez A, Moreno A et al. Endogenous cholecystokinin enhances postprandial gastroesophageal refl ux in humans through extrasphincteric receptors . Gastroenterology 1998; 115: 597-604.
48. Holloway RH, Lyrenas E, Ireland A et al. Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal refl ux. Gut 1997; 40: 449-53.
49. Ledeboer M, Masclee AA, Biemond I et al. Effect of medium-and longchain triglycerides on lower esophageal sphincter pressure: role of CCK. Am J Physiol 1998; 274: G1160-5.
50. Meyer JH, Lembo A, Elashoff JD et al. Duodenal fat intensifi es the perception of heartburn . Gut 2001; 49: 624-8.
51. Zerbib F, Bruley Des Varannes S, Scarpignato C et al. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans . Am J Physiol 1998; 275: G1266-73.
52. Hampel H, Abraham NS, El-Serag HB . Meta-analysis: obesity and the risk for gastroesophageal refl ux disease and its complications . Ann Intern Med 2005; 143: 199-211.
53. Pandolfino JE, El-Serag HB, Zhang Q et al. Obesity: a challenge to esophagogastric junction integrity . Gastroenterology 2006; 130: 639-49.
54. Wu JC, Mui LM, Cheung CM et al. Obesity is associated with increased transient lower esophageal sphincter relaxation . Gastroenterology 2007; 132: 883-9.
55. Stewart JE, Seimon RV, Otto B et al. Marked diff erences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men. Am J Clin Nutr 2011; 93: 703-11.
56. Richter JE, Friedenberg FK . Gastroesophageal refl ux disease . In: Feldman M, Friedman LS, Brandt LJ (eds). Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management . Saunders Elsevier: Philadelphia, PA, 2010, pp. 705-26.
57. Nebel OT, Fornes MF, Castell DO . Symptomatic gastroesophageal refl ux: incidence and precipitating factors . Am J Dig Dis 1976; 21: 953-6.
58. Becker DJ, Sinclair J, Castell DO et al. A comparison of high and low fat meals on postprandial esophageal acid exposure . Am J Gastroenterol 1989; 84: 782-6.
59. Murphy DW, Castell DO . Chocolate and heartburn: evidence of increased esophageal acid exposure aft er chocolate ingestion . Am J Gastroenterol 1988; 83: 633-6.
60. El-Serag HB, Satia JA, Rabeneck L . Dietary intake and the risk of gastro-oesophageal refl ux disease: a cross sectional study in volunteers. Gut 2005; 54: 11-7.
61. Shapiro M, Green C, Bautista JM et al. Assessment of dietary nutrients that infl uence perception of intra-oesophageal acid refl ux events in patients with gastro-oesophageal refl ux disease . Aliment Pharmacol Ther 2007; 25: 93-101.
62. Ruhl CE, Everhart JE . Overweight, but not high dietary fat intake, increases risk of gastroesophageal refl ux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey . Ann Epidemiol 1999; 9: 424-35.
63. Nandurkar S, Locke GR III, Fett S et al. Relationship between body mass index, diet, exercise and gastro-oesophageal refl ux symptoms in a community . Aliment Pharmacol Ther 2004; 20: 497-505.
64. Carvalho RV, Lorena SL, Almeida JR et al. Food intolerance, diet composition, and eating patterns in functional dyspepsia patients . Dig Dis Sci 2010; 55: 60-5.
65. Cuperus P, Keeling PW, Gibney MJ . Eating patterns in functional dyspepsia: a case control study . Eur J Clin Nutr 1996; 50: 520-3.
66. Filipovic BF, Randjelovic T, Kovacevic N et al. Laboratory parameters and nutritional status in patients with functional dyspepsia . Eur J Intern Med 2011; 22: 300-4.
67. Friedlander PH . Food and indigestion. An investigation of possible relationships . Br Med J 1959; 2: 1454-8.
68. Kaess H, Kellermann M, Castro A . Food intolerance in duodenal ulcer patients, non ulcer dyspeptic patients and healthy subjects. A prospective study . Klin Wochenschr 1988; 66: 208-11.
69. Mullan A, Kavanagh P, O ' Mahony P et al. Food and nutrient intakes and eating patterns in functional and organic dyspepsia . Eur J Clin Nutr 1994; 48: 97-105.
70. Houghton LA, Mangall YF, Dwivedi A et al. Sensitivity to nutrients in patients with non-ulcer dyspepsia . Eur J Gastroenterol Hepatol 1993; 5 : 109-14.
71. Saito YA, Locke GR III, Weaver AL et al. Diet and functional gastrointestinal disorders: a population-based case-control study . Am J Gastroenterol 2005; 100: 2743-8.
72. Pilichiewicz AN, Horowitz M, Holtmann GJ et al. Relationship between symptoms and dietary patterns in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2009; 7: 317-22.
73. Passos MC, Serra J, Azpiroz F et al. Impaired refl ex control of intestinal gas transit in patients with abdominal bloating . Gut 2005; 54: 344-8.
74. Salvioli B, Serra J, Azpiroz F et al. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion . Am J Gastroenterol 2006; 101: 1853-7.
75. Serra J . Intestinal gas: has diet anything to do in the absence of a demonstrable malabsorption state? Curr Opin Clin Nutr Metab Care 2012; 15 : 489-93.
76. Simren M, Abrahamsson H, Bjornsson ES . An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome . Gut 2001; 48: 20-7.
77. Simren M, Mansson A, Langkilde AM et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome . Digestion 2001; 63: 108-15.
78. Bhat K, Harper A, Gorard DA . Perceived food and drug allergies in functional and organic gastrointestinal disorders . Aliment Pharmacol Ther 2002; 16: 969-73.
79. Faresjo A, Johansson S, Faresjo T et al. Sex diff erences in dietary coping with gastrointestinal symptoms . Eur J Gastroenterol Hepatol 2010; 22: 327-33.
80. Money ME, Walkowiak J, Virgilio C et al. Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea . Frontline Gastroenterol 2011; 2: 48-56.
81. Halpert A, Dalton CB, Palsson O et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ) . Am J Gastroenterol 2007; 102: 1972-82.
82. Jarrett M, Heitkemper MM, Bond EF et al. Comparison of diet composition in women with and without functional bowel disorder . Gastroenterol Nurs 1994; 16: 253-8.
83. Ostgaard H, Hausken T, Gundersen D et al. Diet and Effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome . Mol Med Report 2012; 5: 1382-90.
84. Sicherer SH, Sampson HA . Food allergy: recent advances in pathophysiology and treatment . Annu Rev Med 2009; 60: 261-77.
85. Prescha A, Pieczynska J, Ilow R et al. Assessment of dietary intake of patients with irritable bowel syndrome . Rocz Panstw Zakl Hig 2009; 60: 185-9.
86. Williams EA, Nai X, Corfe BM . Dietary intakes in people with irritable bowel syndrome . BMC Gastroenterol 2011; 11: 9.
87. Austin GL, Dalton CB, Hu Y et al. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome . Clin Gastroenterol Hepatol 2009; 7: 706-8 e1.
88. Clarke G, Fitzgerald P, Hennessy AA et al. Marked elevations in proinfl ammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome . J Lipid Res 2010; 51: 1186-92.
89. Suarez F, Levitt MD, Adshead J et al. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal . Dig Dis Sci 1999; 44: 1317-21.
90. Leeds JS, Hopper AD, Sidhu R et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insuffi ciency . Clin Gastroenterol Hepatol 2010; 8: 433-8.
91. Money ME, Hofmann AF, Hagey LR et al. Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea . Pancreas 2009; 38: 232-3.
92. Boyle BJ, Long WB, Balistreri WF et al. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fi brosis. Gastroenterology 1980; 78: 950-3.
93. Stern RC, Eisenberg JD, Wagener JS et al. A comparison of the effi cacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fi brosis patients with clinical exocrine pancreatic insuffi ciency. Am J Gastroenterol 2000; 95: 1932-8.
94. Dutta SK, Anand K, Gadacz TR . Bile salt malabsorption in pancreatic insuffi ciency secondary to alcoholic pancreatitis . Gastroenterology 1986; 91: 1243-9.
95. Wong BS, Camilleri M, Carlson P et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea . Clin Gastroenterol Hepatol 2012; 10: 1009-15 e3.
96. Marion-Letellier R, Dechelotte P, Iacucci M et al. Dietary modulation of peroxisome proliferator-activated receptor gamma . Gut 2009; 58: 586-93.
97. Martinez C, Lobo B, Pigrau M et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier . Gut 2013; e-pub ahead of print.
98. Martinez C, Vicario M, Ramos L et al. The jejunum of diarrheapredominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations . Am J Gastroenterol 2012; 107: 736-46.
99. Guarino AH . Treatment of intractable constipation with orlistat: a report of three cases . Pain Med 2005; 6: 327-8.
100. Mueller-Lissner SA, Wald A . Constipation in adults . Clin Evid (Online); advance online publication, 5 July 2010; pii 0413.
101. Faussone-Pellegrini MS, Grover M, Pasricha PJ et al. Ultrastructural diff erences between diabetic and idiopathic gastroparesis . J Cell Mol Med 2012; 16: 1573-81.
102. Grover M, Bernard CE, Pasricha PJ et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium . Neurogastroenterol Motil 2012; 24: 531-9, e249.
103. Grover M, Farrugia G, Lurken MS et al. Cellular changes in diabetic and idiopathic gastroparesis . Gastroenterology 2011; 140: 1575-85, e8.
104. Azpiroz F, Malagelada JR . Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis . Gastroenterology 1987; 92: 934-43.
105. Thumshirn M, Bruninga K, Camilleri M . Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis . Am J Gastroenterol 1997; 92: 1496-500.
106. Heddle R, Collins PJ, Dent J et al. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion . J Gastroenterol Hepatol 1989; 4: 437-47.
107. Azpiroz F, Tack J . Gastric disorders . In: Spiller R, Grundy D (eds). Pathophysiology of the Enteric Nervous System: A Basis for Understanding Functional Diseases . Wiley-Blackwell: Oxford, 2004, pp. 126-33.
108. Abell TL, Bernstein RK, Cutts T et al. Treatment of gastroparesis: a multidisciplinary clinical review . Neurogastroenterol Motil 2006; 18 : 263-83.
109. Parkman HP, Camilleri M, Farrugia G et al. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting . Neurogastroenterol Motil 2010; 22: 113-33.
110. Parrish CR . Nutrition concerns for the patient with gastroparesis . Curr Gastroenterol Rep 2007; 9: 295-302.
111. Little TJ, Feinle-Bisset C . Effects of dietary fat on appetite and energy intake in health and obesity-oral and gastrointestinal sensory contributions . Physiol Behav 2011; 104: 613-20.
112. Feinle C, D ' Amato M, Read NW . Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid . Gastroenterology 1996; 110: 1379-85.
113. Fried M, Erlacher U, Schwizer W et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991; 101: 503-11.
114. Karaus M, Niederau C . Effects of CCK-receptor antagonist on colonic motor activity in dogs . Neurogastroenterol Motil 1995; 7: 63-71.
115. Chua AS, Dinan TG, Rovati LC et al. Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia . Ann N Y Acad Sci 1994; 713: 298-9.
116. Lobo B, Serra J, Azpiroz F et al. Dexloxiglumide, a CCK1-antagonist, improves gas-related symptoms in healthy subjects . Gastroenterology 2006; 130: A597.
117. Degen L, Oesch S, Casanova M et al. Effect of peptide YY3-36 on food intake in humans . Gastroenterology 2005; 129: 1430-6.
118. Pilichiewicz AN, Feltrin KL, Horowitz M et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008; 103: 2613-23.
119. Lanzini A, Magni P, Petroni ML et al. Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet . Aliment Pharmacol Ther 2006; 23: 907-13.
120. Sjolund K, Ekman R, Lindgren S et al. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome . Scand J Gastroenterol 1996; 31: 1110-4.
121. Little TJ, Feinle-Bisset C . Oral and gastrointestinal sensing of dietary fat and appetite regulation in humans: modifi cation by diet and obesity. Front Neurosci 2010; 4: 178.
122. Lassman DJ, McKie S, Gregory LJ et al. Defi ning the role of cholecystokinin in the lipid-induced human brain activation matrix . Gastroenterology 2010; 138: 1514-24.
123. Lawal A, Kern M, Sanjeevi A et al. Neurocognitive processing of esophageal central sensitization in the insula and cingulate gyrus . Am J Physiol Gastrointest Liver Physiol 2008; 294: G787-94.
124. Tillisch K, Mayer EA, Labus JS . Quantitative meta-analysis identifi es brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 2011; 140: 91-100.
125. Van Oudenhove L, Vandenberghe J, Dupont P et al. Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history . Gastroenterology 2010; 139: 36-47.
126. Pehl C, Waizenhoefer A, Wendl B et al. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal refl ux in healthy subjects . Am J Gastroenterol 1999; 94: 1192-6.
127. DeVault KR, Castell DO . Updated guidelines for the diagnosis and treatment of gastroesophageal refl ux disease . Am J Gastroenterol 2005; 100: 190-200.
128. Boeckxstaens GE, Hirsch DP, van den Elzen BD et al. Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function . Gastroenterology 2001; 121: 1054-63.
129. Delgado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia . Gastroenterology 2004; 127: 1685-94.
130. Hjelland IE, Ofstad AP, Narvestad JK et al. Drink tests in functional dyspepsia: which drink is best? Scand J Gastroenterol 2004; 39: 933-7.
131. Kindt S, Coulie B, Wajs E et al. Reproducibility and symptomatic predictors of a slow nutrient drinking test in health and in functional dyspepsia. Neurogastroenterol Motil 2008; 20: 320-9.
132. Tack J, Caenepeel P, Piessevaux H et al. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia . Gut 2003; 52: 1271-7.
133. van den Elzen BD, Bennink RJ, Holman R et al. Impaired drinking capacity in patients with functional dyspepsia: intragastric distribution and distal stomach volume . Neurogastroenterol Motil 2007; 19: 968-76.
134. Bisschops R, Karamanolis G, Arts J et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia . Gut 2008; 57: 1495-503.
135. Taggart D, Billington BP . Fatty foods and dyspepsia . Lancet 1966; 2: 465-6.
136. Feinle-Bisset C, Meier B, Fried M et al. Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia . Gut 2003; 52: 1414-8.